HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shoulder Dystocia

Obstetric complication during OBSTETRIC DELIVERY in which exit of the fetus is delayed due to physical obstruction involving fetal shoulder(s).
Also Known As:
Dystocia, Fetal Shoulder; Dystocia, Shoulder; Fetal Shoulder Dystocias; Shoulder Dystocia, Fetal; Shoulder Dystocias; Fetal Shoulder Dystocia
Networked: 498 relevant articles (12 outcomes, 27 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Pre-Eclampsia (Preeclampsia)
2. Hypoglycemia (Reactive Hypoglycemia)
3. Wounds and Injuries (Trauma)
4. Birth Weight (Birth Weights)
5. Postpartum Hemorrhage

Experts

1. Caughey, Aaron B: 6 articles (11/2019 - 11/2005)
2. Allen, Robert H: 6 articles (09/2007 - 09/2004)
3. Chauhan, Suneet P: 5 articles (01/2022 - 04/2012)
4. Ouzounian, Joseph G: 5 articles (10/2012 - 06/2005)
5. Crowther, Caroline A: 4 articles (01/2017 - 06/2005)
6. Gherman, Robert B: 4 articles (04/2012 - 06/2005)
7. Gurewitsch, Edith D: 4 articles (02/2006 - 09/2004)
8. Johansen, Marianne: 3 articles (11/2021 - 01/2009)
9. Blackwell, Sean C: 3 articles (01/2021 - 02/2015)
10. Sørensen, Jette Led: 3 articles (04/2020 - 01/2009)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Shoulder Dystocia:
1. Insulin (Novolin)FDA Link
2. Oxytocin (Pitocin)FDA LinkGeneric
3. Glucose (Dextrose)FDA LinkGeneric
4. C-PeptideIBA
01/01/2021 - "Accordingly, the treatment of mild GDM significantly reduced the risk of macrosomia (OR = 0.3; 95%CI = 0.3-0.4), large for gestational age (OR = 0.4; 95%CI = 0.3-0.5), shoulder dystocia (OR = 0.3; 95%CI = 0.2-0.6), caesarean-section (OR = 0.8; 95%CI = 0.7-0.9), preeclampsia (OR = 0.4; 95%CI = 0.3-0.6), elevated cord C-peptide (OR = 0.7; 95%CI = 0.6-0.9), and respiratory distress syndrome (OR = 0.7; 95%CI = 0.5-0.9) compared to untreated counterparts. "
04/01/2012 - "Adverse pregnancy outcomes included birth weight, newborn percent body fat, and cord C-peptide >90th percentiles, primary cesarean delivery, preeclampsia, and shoulder dystocia/birth injury. "
02/01/2011 - "Groups were compared by test of trend for a composite perinatal outcome (neonatal hypoglycemia, hyperbilirubinemia, elevated cord C-peptide level, and perinatal trauma or death), frequency of large for gestational age neonates, shoulder dystocia, and pregnancy-related hypertension. "
09/01/2010 - "The results of the hyperglycemia and adverse pregnancy outcome (HAPO) study demonstrate a linear association between increasing levels of fasting, 1- and 2-h plasma glucose post a 75 g oral glucose tolerance test to several significant outcome endpoints, such as birth weight above the 90th percentile, cord blood serum C-peptide level above the 90th percentile, primary cesarean delivery, clinical neonatal hypoglycemia, premature delivery, shoulder dystocia or birth injury, intensive neonatal care admission, hyperbilirubinemia, and preeclampsia. "
5. Insulin Aspart (NovoLog)FDA Link
6. ORALIT (ORS)IBA
7. SolutionsIBA
8. Oxygen (Dioxygen)IBA
9. Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
10. Opiate AlkaloidsIBA

Therapies and Procedures

1. Cesarean Section (Caesarean Section)
2. Resuscitation
3. Glycemic Control
02/01/2018 - "Improved glycemic control allows reducing perinatal morbidity and mortality and, specifically, the risk of macrosomia and shoulder dystocia which are the most common complications associated with GDM. "
01/01/2022 - "For individuals in the stably optimal trajectory group, there were lower risks of cesarean delivery (adjusted relative risk [aRR], 0.93 [95% CI, 0.89-0.96]), shoulder dystocia (aRR, 0.75 [95% CI, 0.61-0.92]), large-for-gestational age (aRR, 0.74 [95% CI, 0.69-0.80]), and neonatal intensive care unit admission (aRR, 0.90 [95% CI, 0.83-0.97]), while for patients in the slowly improving to suboptimal glycemic control trajectory group, risks were higher for cesarean delivery (aRR, 1.18 [95% CI, 1.12-1.24]; (P for trend < .001), shoulder dystocia (aRR, 1.41 [95% CI, 1.12-1.78]; P for trend < .001), large-for-gestational-age (aRR, 1.42 [95% CI, 1.31-1.53]; P for trend < .001), and neonatal intensive care unit admission (aRR, 1.33 [95% CI, 1.20-1.47]; P for trend < .001). "
11/01/2014 - "Three out of four births complicated by shoulder dystocia and BW <4,000 g, occurred in Group 1 (p = 0.076) and were associated with no glycemic control. "
02/01/2013 - "Randomized trials of glycemic control in pregnancies complicated by gestational diabetes reveal decreased rates of macrosomia and shoulder dystocia among those treated. "
12/03/2023 - "Since the risks for macrosomia, shoulder dystocia, and neonatal hypoglycemia are higher in early-onset GDM, these women should undergo strict glycemic control, intensive monitoring, and careful neonatal evaluation."
4. Surgical Instruments (Clip)
5. Therapeutics